VicTORia: A Randomised Phase II Study to Compare Vinorelbine in Combination with the MTOR Inhibitor Everolimus versus Vinorelbine Monotherapy for Second-Line Chemotherapy in Advanced HER2-Negative Breast Cancer. 26. Juli 2019 Decker, T., Marschner, N., Muendlein, A., Welt, A., Hagen, V., Rauh, J., Schröder, H., Jaehnig, P., Potthoff, K., Lerchenmüller, C. 2019. Breast Cancer Research and Treatment, 2019. https://doi.org/10.1007/s10549-019-05280-2. Abstract Survival after secondary liver resection in metastatic colorectal cancer. A comparative analysis of the LICC trial with historical controls (CELIM, FIRE-3) Moehler, M., Folprecht, M, Heinemann, V., Holch, J., Maderer, A., Kasper, S., Hegewisch-Becker, S., Schröder, J., Overkamp, F., Kullmann, F., Bechstein, W., Vöhringer, M., Öllinger,… Weiterlesen Patient-based prospective real-world data analysis shows that the duration of treatment interruptions with subsequent resumption of idelalisib therapy can vary from days to months. Hoechstetter, M., Knauf, W., Eissmann, P., Hucke, N., von Troostenburg, A., Ramroth, H., Abenhardt, W., Rummel, M., 2019. HemaSphere 3 (PS1163), 528–529. https://doi.org/10.1097/01.HS9.0000562936.05518.43… Weiterlesen